Idexx Laboratories Inc. IDXX
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $4.3B | +10% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $2.7B | +12% | FY ending Dec 31, 2025 |
| Operating income | $1.4B | +21% | FY ending Dec 31, 2025 |
| Net income | $1.1B | +19% | FY ending Dec 31, 2025 |
| Earnings per share | $13.08 | +23% | FY ending Dec 31, 2025 |
| Research & development | $251.2M | +14% | FY ending Dec 31, 2025 |
| Cash from operations | $1.2B | +27% | FY ending Dec 31, 2025 |
| Capital spending | $124.7M | +3% | FY ending Dec 31, 2025 |
| Share buybacks | $1.2B | +45% | FY ending Dec 31, 2025 |
| Cash | $180.1M | -38% | FY ending Dec 31, 2025 |
| Long-term debt | $374.8M | -17% | FY ending Dec 31, 2025 |
| Shareholders' equity | $1.6B | +1% | FY ending Dec 31, 2025 |
| Shares outstanding | 80M | -2% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 8 sales ($37.7M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Lawrence D KingsleyDirector | Sold | 2,203 | $532.08 | $1.2M | Sep 4, 2026 |
| Nimrata HuntExecutive Vice President | Sold | 1,758 | $634.57 | $1.1M | Mar 3, 2026 |
| Jonathan Jay MazelskyPresident and CEO, Director | Sold13 fills | 23,326 | $657.55 avg | $15.3M | Feb 26, 2026 |
| Nimrata HuntExecutive Vice President | Sold | 2,693 | $661.54 | $1.8M | Feb 26, 2026 |
| Michael G EricksonExecutive Vice President | Sold6 fills | 5,371 | $627.38 avg | $3.4M | Feb 17, 2026 |
| Sophie V. VandebroekDirector | Sold2 fills | 1,464 | $628.62 avg | $920K | Feb 17, 2026 |
| George FennellExecutive Vice President | Sold8 fills | 11,345 | $646.72 avg | $7.3M | Feb 10, 2026 |
| Nimrata HuntExecutive Vice President | Sold4 fills | 9,425 | $703.34 avg | $6.6M | Nov 7, 2025 |
Other insider moves (44): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Lawrence D KingsleyDirector | Option exercise | 2,203 | $114.17 | $252K | Sep 4, 2026 |
| Andrew EmersonEVP, CFO and Treasurer | Option exercise | 265 | $178.26 | $47K | Aug 20, 2026 |
| Andrew EmersonEVP, CFO and Treasurer | Tax withholding | 86 | – | – | Aug 20, 2026 |
| Joseph L HooleyDirector | Award | 49 | $558.80 | $27K | Jul 30, 2026 |
| George FennellExecutive Vice President | Tax withholding | 284 | $566.79 | $161K | Jun 1, 2026 |
| George FennellExecutive Vice President | Option exercise | 639 | – | – | Jun 1, 2026 |
| Sophie V. VandebroekDirector | Option exercise | 257 | – | – | May 7, 2026 |
| M Anne SzostakDirector | Option exercise | 257 | – | – | May 7, 2026 |
| Karen PeacockDirector | Option exercise | 101 | – | – | May 7, 2026 |
| Lawrence D KingsleyDirector | Option exercise2 fills | 339 | – | – | May 7, 2026 |
| Daniel M JuniusDirector | Option exercise | 257 | – | – | May 7, 2026 |
| Joseph L HooleyDirector | Option exercise | 158 | – | – | May 7, 2026 |
| Joseph L HooleyDirector | Award | 43 | $560.80 | $24K | Apr 30, 2026 |
| Sharon E. UnderbergEVP, GC & Corporate Secretary | Option exercise | 197 | $505.53 | $100K | Mar 3, 2026 |
| Jonathan Jay MazelskyPresident and CEO, Director | Option exercise | 197 | $505.53 | $100K | Feb 27, 2026 |
| Jonathan Jay MazelskyPresident and CEO, Director | Option exercise | 23,326 | $141.60 | $3.3M | Feb 26, 2026 |
| Michael G EricksonExecutive Vice President | Option exercise5 fills | 2,399 | $227.83 avg | $547K | Feb 19, 2026 |
| Michael G EricksonExecutive Vice President | Option exercise2 fills | 5,371 | $170.13 avg | $914K | Feb 17, 2026 |
| Sophie V. VandebroekDirector | Option exercise | 945 | $333.90 | $316K | Feb 17, 2026 |
| Nimrata HuntExecutive Vice President | Tax withholding | 1,154 | $629.35 | $726K | Feb 14, 2026 |
| Michael G EricksonExecutive Vice President | Tax withholding | 974 | $629.35 | $613K | Feb 14, 2026 |
| Jonathan Jay MazelskyPresident and CEO, Director | Tax withholding | 915 | $629.35 | $576K | Feb 14, 2026 |
| Michael SchreckExecutive Vice President | Tax withholding | 876 | $629.35 | $551K | Feb 14, 2026 |
| Martin Alexander SmithExecutive Vice President | Tax withholding | 302 | $629.35 | $190K | Feb 14, 2026 |
| Sharon E. UnderbergEVP, GC & Corporate Secretary | Tax withholding | 251 | $629.35 | $158K | Feb 14, 2026 |
| Michael LaneExecutive Vice President | Tax withholding | 221 | $629.35 | $139K | Feb 14, 2026 |
| George FennellExecutive Vice President | Tax withholding | 199 | $629.35 | $125K | Feb 14, 2026 |
| Michael Perkins JohnsonExecutive Vice President | Tax withholding | 178 | $629.35 | $112K | Feb 14, 2026 |
| Andrew EmersonEVP, CFO and Treasurer | Tax withholding | 123 | $629.35 | $77K | Feb 14, 2026 |
| Sharon E. UnderbergEVP, GC & Corporate Secretary | Option exercise4 fills | 832 | – | – | Feb 14, 2026 |
| Martin Alexander SmithExecutive Vice President | Option exercise4 fills | 1,004 | – | – | Feb 14, 2026 |
| Michael SchreckExecutive Vice President | Option exercise5 fills | 1,959 | – | – | Feb 14, 2026 |
| Jonathan Jay MazelskyPresident and CEO, Director | Option exercise2 fills | 2,057 | – | – | Feb 14, 2026 |
| Michael LaneExecutive Vice President | Option exercise4 fills | 1,092 | – | – | Feb 14, 2026 |
| Michael Perkins JohnsonExecutive Vice President | Option exercise3 fills | 573 | – | – | Feb 14, 2026 |
| Nimrata HuntExecutive Vice President | Option exercise5 fills | 2,587 | – | – | Feb 14, 2026 |
| George FennellExecutive Vice President | Option exercise4 fills | 454 | – | – | Feb 14, 2026 |
| Michael G EricksonExecutive Vice President | Option exercise6 fills | 2,363 | – | – | Feb 14, 2026 |
| Andrew EmersonEVP, CFO and Treasurer | Option exercise5 fills | 456 | – | – | Feb 14, 2026 |
| George FennellExecutive Vice President | Option exercise | 11,345 | $67.85 | $770K | Feb 10, 2026 |
| George FennellExecutive Vice President | Option exercise | 1,476 | $67.85 | $100K | Feb 9, 2026 |
| Joseph L HooleyDirector | Award | 36 | $670.46 | $24K | Jan 30, 2026 |
| Nimrata HuntExecutive Vice President | Option exercise2 fills | 12,530 | $382.28 avg | $4.8M | Nov 7, 2025 |
| Joseph L HooleyDirector | Award | 39 | $628.54 | $25K | Oct 30, 2025 |
Trades by members of Congress
4 members reported 11 buys and 9 sales since Feb 25, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| April McClain Delaney | Sold | $1,001–$15K | Jan 13, 2026 | Feb 2, 2026 | Child |
| April McClain Delaney | Sold some | $1,001–$15K | Dec 2, 2025 | Jan 5, 2026 | Child |
| April McClain Delaney | Sold some | $1,001–$15K | Oct 29, 2025 | Nov 4, 2025 | Child |
| April McClain Delaney | Sold some | $1,001–$15K | Oct 16, 2025 | Nov 4, 2025 | Child |
| Byron Donalds R | Bought | $1,001–$15K | Sep 4, 2025 | Oct 7, 2025 | Self |
| Byron Donalds R | Bought | $1,001–$15K | Sep 4, 2025 | Oct 7, 2025 | Spouse |
| April McClain Delaney | Sold some | $1,001–$15K | Aug 7, 2025 | Sep 2, 2025 | Child |
| April McClain Delaney | Sold some | $1,001–$15K | Aug 1, 2025 | Sep 2, 2025 | Child |
| April McClain Delaney | Sold some | $1,001–$15K | Jul 9, 2025 | Aug 5, 2025 | Child |
| Jefferson Shreve R | Sold | $100K–$250K | May 12, 2025 | Jun 22, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | May 15, 2025 | Jun 9, 2025 | Self |
| Jefferson Shreve R | Bought | $50K–$100K | Apr 7, 2025 | May 8, 2025 | Self |
| April McClain Delaney | Bought | $1,001–$15K | Apr 9, 2025 | May 2, 2025 | Child |
| April McClain Delaney | Bought | $1,001–$15K | Apr 7, 2025 | May 2, 2025 | Child |
| April McClain Delaney | Bought | $1,001–$15K | Apr 4, 2025 | May 2, 2025 | Child |
| April McClain Delaney | Bought | $1,001–$15K | Apr 1, 2025 | May 2, 2025 | Child |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | Apr 8, 2025 | Apr 28, 2025 | Self |
| Jefferson Shreve R | Bought | $15K–$50K | Mar 13, 2025 | Apr 11, 2025 | Self |
| April McClain Delaney | Bought | $1,001–$15K | Mar 14, 2025 | Apr 2, 2025 | Child |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | Feb 25, 2025 | Mar 27, 2025 | Self |
Latest SEC filings
- Insider plans to sell 144 · Sep 4, 2026
- Quarterly report 10-Q · Aug 4, 2026
- News filing: Quarterly results 8-K · Aug 4, 2026
- Insider plans to sell 144 · May 20, 2026
- News filing: Bylaws or fiscal year changed, Shareholder vote results 8-K · May 15, 2026
- Quarterly report 10-Q · May 5, 2026
- News filing: Quarterly results 8-K · May 5, 2026
- Shareholder meeting proxy DEF 14A · Mar 27, 2026
- News filing: Executive or board change 8-K · Mar 26, 2026
- Insider plans to sell 144 · Mar 3, 2026
- Insider plans to sell 144 · Feb 26, 2026
- Insider plans to sell 144 · Feb 25, 2026
- Annual report 10-K · Feb 20, 2026
- Insider plans to sell 144 · Feb 17, 2026
- Insider plans to sell 144 · Feb 17, 2026
- News filing: Executive or board change 8-K · Feb 13, 2026
- Insider plans to sell 144 · Feb 10, 2026
- News filing: Quarterly results 8-K · Feb 2, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Jan 13, 2026
- News filing: Signed a major agreement, Took on new debt 8-K · Nov 13, 2025
- Insider plans to sell 144 · Nov 7, 2025
- Quarterly report 10-Q · Nov 3, 2025
- News filing: Quarterly results 8-K · Nov 3, 2025
- News filing: Executive or board change 8-K · Oct 7, 2025
- Insider plans to sell 144 · Aug 22, 2025
About Idexx Laboratories Inc.
Business description
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Sector
- Life Sciences
- Headquarters
- Westbrook, ME
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 874716
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.